Biodesix, Inc. provided revenue guidance for the year 2022. The company anticipated generating between $37.5 million to $39.5 million in total revenue in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.325 USD | -1.12% | -8.62% | -27.99% |
05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.99% | 194M | |
-25.06% | 7.76B | |
+67.56% | 4.35B | |
+2.59% | 2.67B | |
-2.45% | 2.64B | |
-47.56% | 2.1B | |
-17.86% | 1.73B | |
-19.62% | 1.52B | |
+12.59% | 1.18B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2022